|Bid||14.27 x 400|
|Ask||14.98 x 500|
|Day's Range||14.44 - 14.90|
|52 Week Range||11.30 - 67.90|
|PE Ratio (TTM)||4.60|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
Merrimack Pharmaceuticals Inc (NASDAQ:MACK), a pharmaceuticals, biotechnology and life sciences company based in United States, saw a significant share price rise of over 20% in the past couple of monthsRead More...
Otonomy shares rose in premarket trading on Aug. 31 after plunging Wednesday on the heels of disappointing data in a Phase 3 study of Otividex in patients with Meniere's disease.
Q2 2017 Merrimack Pharmaceuticals Inc Earnings Call